| 000 | 01721 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250515164642.0 | ||
| 264 | 0 | _c20090722 | |
| 008 | 200907s 0 0 eng d | ||
| 022 | _a1873-2763 | ||
| 024 | 7 |
_a10.1016/j.bone.2009.03.667 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGao, Qi | |
| 245 | 0 | 0 |
_aEffects of global or targeted deletion of the EP4 receptor on the response of osteoblasts to prostaglandin in vitro and on bone histomorphometry in aged mice. _h[electronic resource] |
| 260 |
_bBone _cJul 2009 |
||
| 300 |
_a98-103 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural | ||
| 650 | 0 | 4 |
_aAging _xdrug effects |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBody Composition _xdrug effects |
| 650 | 0 | 4 |
_aBone and Bones _xanatomy & histology |
| 650 | 0 | 4 | _aBreeding |
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 |
_aDinoprostone _xpharmacology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGene Deletion |
| 650 | 0 | 4 | _aGenotype |
| 650 | 0 | 4 | _aHeterozygote |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 |
_aNitrobenzenes _xpharmacology |
| 650 | 0 | 4 |
_aOsteoblasts _xdrug effects |
| 650 | 0 | 4 |
_aReceptors, Prostaglandin E _xmetabolism |
| 650 | 0 | 4 | _aReceptors, Prostaglandin E, EP4 Subtype |
| 650 | 0 | 4 |
_aSulfonamides _xpharmacology |
| 650 | 0 | 4 | _aSurvival Rate |
| 650 | 0 | 4 | _aWeaning |
| 700 | 1 | _aZhan, Peili | |
| 700 | 1 | _aAlander, Cynthia B | |
| 700 | 1 | _aKream, Barbara E | |
| 700 | 1 | _aHao, Chuanming | |
| 700 | 1 | _aBreyer, Matthew D | |
| 700 | 1 | _aPilbeam, Carol C | |
| 700 | 1 | _aRaisz, Lawrence G | |
| 773 | 0 |
_tBone _gvol. 45 _gno. 1 _gp. 98-103 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.bone.2009.03.667 _zAvailable from publisher's website |
| 999 |
_c18780070 _d18780070 |
||